APO Research
Talk to an analyst

APO RESEARCH · REPORT

lncRNA Sequencing Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global lncRNA Sequencing Service Market Outlook and Growth Opportunities 2026

12 August 2026198 pages

Choose your research edition.

Industry ResearchlncRNA Sequencing Service Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal lncRNA Sequencing Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal lncRNA Sequencing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal lncRNA Sequencing Service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal lncRNA Sequencing Service Market Analysis and Forecast 2026-2032170 pages · $4,950 USD

Market perspective

The global lncRNA Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for lncRNA Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for lncRNA Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for lncRNA Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the lncRNA Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the lncRNA Sequencing Service market include LC Sciences, Creative Biolabs, Eurofins Scientific, CD Genomics, Novogene Co, Ltd., Beijing Compass Biotechnology Co., Ltd., Biomarker Technologies, Azenta and BGI Genomics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global lncRNA Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of lncRNA Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents lncRNA Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global lncRNA Sequencing Service market.

lncRNA Sequencing Service Segment by Company

LC Sciences

Creative Biolabs

Eurofins Scientific

CD Genomics

Novogene Co, Ltd.

Beijing Compass Biotechnology Co., Ltd.

Biomarker Technologies

Azenta

BGI Genomics

Annoroad Gene Technology

lncRNA Sequencing Service Segment by Type

Normal-depth Sequencing

High-depth Sequencing

lncRNA Sequencing Service Segment by Application

Agriculture

Medical

lncRNA Sequencing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global lncRNA Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the lncRNA Sequencing Service key companies, revenue, market share, and recent developments.

3. To split the lncRNA Sequencing Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions lncRNA Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify lncRNA Sequencing Service significant trends, drivers, influence factors in global and regions.

6. To analyze lncRNA Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global lncRNA Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of lncRNA Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of lncRNA Sequencing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global lncRNA Sequencing Service industry.

Chapter 3: Detailed analysis of lncRNA Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of lncRNA Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of lncRNA Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. lncRNA Sequencing Service Industry Trends Table 2. lncRNA Sequencing Service Industry Drivers Table 3. lncRNA Sequencing Service Industry Opportunities and Challenges Table 4. lncRNA Sequencing Service Industry Restraints Table 5. Global lncRNA Sequencing Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global lncRNA Sequencing Service Revenue Share by Company (2021-2026) Table 7. Global lncRNA Sequencing Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global lncRNA Sequencing Service Key Company Manufacturing Base & Headquarters Table 9. Global lncRNA Sequencing Service Company, Product Type & Application Table 10. Global lncRNA Sequencing Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global lncRNA Sequencing Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Normal-depth Sequencing Table 15. Significant Companies of High-depth Sequencing Table 16. Global lncRNA Sequencing Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global lncRNA Sequencing Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global lncRNA Sequencing Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global lncRNA Sequencing Service Sales Value Share by Type (2021-2026) Table 20. Global lncRNA Sequencing Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Agriculture Table 22. Significant Companies of Medical Table 23. Global lncRNA Sequencing Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global lncRNA Sequencing Service Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global lncRNA Sequencing Service Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global lncRNA Sequencing Service Sales Value Share by Application (2021-2026) Table 27. Global lncRNA Sequencing Service Sales Value Share by Application (2027-2032) Table 28. Global lncRNA Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global lncRNA Sequencing Service Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global lncRNA Sequencing Service Sales Value Share by Region (2021-2026) Table 31. Global lncRNA Sequencing Service Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global lncRNA Sequencing Service Sales Value Share by Region (2027-2032) Table 33. Global lncRNA Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global lncRNA Sequencing Service Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global lncRNA Sequencing Service Sales Value Market Share by Country (2021-2026) Table 36. Global lncRNA Sequencing Service Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global lncRNA Sequencing Service Sales Value Market Share by Country (2027-2032) Table 38. LC Sciences Company Information Table 39. LC Sciences Business Overview Table 40. LC Sciences lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. LC Sciences lncRNA Sequencing Service Product Portfolio Table 42. LC Sciences Recent Development Table 43. Creative Biolabs Company Information Table 44. Creative Biolabs Business Overview Table 45. Creative Biolabs lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Creative Biolabs lncRNA Sequencing Service Product Portfolio Table 47. Creative Biolabs Recent Development Table 48. Eurofins Scientific Company Information Table 49. Eurofins Scientific Business Overview Table 50. Eurofins Scientific lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Eurofins Scientific lncRNA Sequencing Service Product Portfolio Table 52. Eurofins Scientific Recent Development Table 53. CD Genomics Company Information Table 54. CD Genomics Business Overview Table 55. CD Genomics lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. CD Genomics lncRNA Sequencing Service Product Portfolio Table 57. CD Genomics Recent Development Table 58. Novogene Co, Ltd. Company Information Table 59. Novogene Co, Ltd. Business Overview Table 60. Novogene Co, Ltd. lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Novogene Co, Ltd. lncRNA Sequencing Service Product Portfolio Table 62. Novogene Co, Ltd. Recent Development Table 63. Beijing Compass Biotechnology Co., Ltd. Company Information Table 64. Beijing Compass Biotechnology Co., Ltd. Business Overview Table 65. Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Product Portfolio Table 67. Beijing Compass Biotechnology Co., Ltd. Recent Development Table 68. Biomarker Technologies Company Information Table 69. Biomarker Technologies Business Overview Table 70. Biomarker Technologies lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Biomarker Technologies lncRNA Sequencing Service Product Portfolio Table 72. Biomarker Technologies Recent Development Table 73. Azenta Company Information Table 74. Azenta Business Overview Table 75. Azenta lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Azenta lncRNA Sequencing Service Product Portfolio Table 77. Azenta Recent Development Table 78. BGI Genomics Company Information Table 79. BGI Genomics Business Overview Table 80. BGI Genomics lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. BGI Genomics lncRNA Sequencing Service Product Portfolio Table 82. BGI Genomics Recent Development Table 83. Annoroad Gene Technology Company Information Table 84. Annoroad Gene Technology Business Overview Table 85. Annoroad Gene Technology lncRNA Sequencing Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Annoroad Gene Technology lncRNA Sequencing Service Product Portfolio Table 87. Annoroad Gene Technology Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. lncRNA Sequencing Service Product Image Figure 2. Global lncRNA Sequencing Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global lncRNA Sequencing Service Market Size (2021-2032) & (US$ Million) Figure 4. Global lncRNA Sequencing Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Normal-depth Sequencing Image Figure 8. High-depth Sequencing Image Figure 9. Global lncRNA Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global lncRNA Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global lncRNA Sequencing Service Sales Value Share by Type (2021-2032) Figure 12. Agriculture Image Figure 13. Medical Image Figure 14. Global lncRNA Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global lncRNA Sequencing Service Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global lncRNA Sequencing Service Sales Value Share by Application (2021-2032) Figure 17. Global lncRNA Sequencing Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global lncRNA Sequencing Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America lncRNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 20. North America lncRNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe lncRNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 22. Europe lncRNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific lncRNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific lncRNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America lncRNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 26. South America lncRNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa lncRNA Sequencing Service Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa lncRNA Sequencing Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt lncRNA Sequencing Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Normal-depth Sequencing
  • High-depth Sequencing
Applications
  • Agriculture
  • Medical
Companies covered
  • LC Sciences
  • Creative Biolabs
  • Eurofins Scientific
  • CD Genomics
  • Novogene Co, Ltd.
  • Beijing Compass Biotechnology Co., Ltd.
  • Biomarker Technologies
  • Azenta
  • BGI Genomics
  • Annoroad Gene Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global lncRNA Sequencing Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global lncRNA Sequencing Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 lncRNA Sequencing Service Market Dynamics
  1. 2.1 lncRNA Sequencing Service Industry Trends
  2. 2.2 lncRNA Sequencing Service Industry Drivers
  3. 2.3 lncRNA Sequencing Service Industry Opportunities and Challenges
  4. 2.4 lncRNA Sequencing Service Industry Restraints
3 lncRNA Sequencing Service Market by Company
  1. 3.1 Global lncRNA Sequencing Service Company Revenue Ranking in 2025
  2. 3.2 Global lncRNA Sequencing Service Revenue by Company (2021-2026)
  3. 3.3 Global lncRNA Sequencing Service Company Ranking (2024-2026)
  4. 3.4 Global lncRNA Sequencing Service Company Manufacturing Base and Headquarters
  5. 3.5 Global lncRNA Sequencing Service Company Product Type and Application
  6. 3.6 Global lncRNA Sequencing Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global lncRNA Sequencing Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 lncRNA Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 lncRNA Sequencing Service Market by Type
  1. 4.1 lncRNA Sequencing Service Type Introduction
  2. 4.1.1 Normal-depth Sequencing
  3. 4.1.2 High-depth Sequencing
  4. 4.2 Global lncRNA Sequencing Service Sales Value by Type
  5. 4.2.1 Global lncRNA Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global lncRNA Sequencing Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global lncRNA Sequencing Service Sales Value Share by Type (2021-2032)
5 lncRNA Sequencing Service Market by Application
  1. 5.1 lncRNA Sequencing Service Application Introduction
  2. 5.1.1 Agriculture
  3. 5.1.2 Medical
  4. 5.2 Global lncRNA Sequencing Service Sales Value by Application
  5. 5.2.1 Global lncRNA Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global lncRNA Sequencing Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global lncRNA Sequencing Service Sales Value Share by Application (2021-2032)
6 lncRNA Sequencing Service Regional Value Analysis
  1. 6.1 Global lncRNA Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global lncRNA Sequencing Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global lncRNA Sequencing Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global lncRNA Sequencing Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America lncRNA Sequencing Service Sales Value (2021-2032)
  7. 6.3.2 North America lncRNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe lncRNA Sequencing Service Sales Value (2021-2032)
  10. 6.4.2 Europe lncRNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific lncRNA Sequencing Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific lncRNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America lncRNA Sequencing Service Sales Value (2021-2032)
  16. 6.6.2 South America lncRNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa lncRNA Sequencing Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa lncRNA Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 lncRNA Sequencing Service Country-level Value Analysis
  1. 7.1 Global lncRNA Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global lncRNA Sequencing Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global lncRNA Sequencing Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global lncRNA Sequencing Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt lncRNA Sequencing Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt lncRNA Sequencing Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt lncRNA Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 LC Sciences
  2. 8.1.1 LC Sciences Company Information
  3. 8.1.2 LC Sciences Business Overview
  4. 8.1.3 LC Sciences lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 LC Sciences lncRNA Sequencing Service Product Portfolio
  6. 8.1.5 LC Sciences Recent Developments
  7. 8.2 Creative Biolabs
  8. 8.2.1 Creative Biolabs Company Information
  9. 8.2.2 Creative Biolabs Business Overview
  10. 8.2.3 Creative Biolabs lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Creative Biolabs lncRNA Sequencing Service Product Portfolio
  12. 8.2.5 Creative Biolabs Recent Developments
  13. 8.3 Eurofins Scientific
  14. 8.3.1 Eurofins Scientific Company Information
  15. 8.3.2 Eurofins Scientific Business Overview
  16. 8.3.3 Eurofins Scientific lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eurofins Scientific lncRNA Sequencing Service Product Portfolio
  18. 8.3.5 Eurofins Scientific Recent Developments
  19. 8.4 CD Genomics
  20. 8.4.1 CD Genomics Company Information
  21. 8.4.2 CD Genomics Business Overview
  22. 8.4.3 CD Genomics lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CD Genomics lncRNA Sequencing Service Product Portfolio
  24. 8.4.5 CD Genomics Recent Developments
  25. 8.5 Novogene Co, Ltd.
  26. 8.5.1 Novogene Co, Ltd. Company Information
  27. 8.5.2 Novogene Co, Ltd. Business Overview
  28. 8.5.3 Novogene Co, Ltd. lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novogene Co, Ltd. lncRNA Sequencing Service Product Portfolio
  30. 8.5.5 Novogene Co, Ltd. Recent Developments
  31. 8.6 Beijing Compass Biotechnology Co., Ltd.
  32. 8.6.1 Beijing Compass Biotechnology Co., Ltd. Company Information
  33. 8.6.2 Beijing Compass Biotechnology Co., Ltd. Business Overview
  34. 8.6.3 Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Beijing Compass Biotechnology Co., Ltd. lncRNA Sequencing Service Product Portfolio
  36. 8.6.5 Beijing Compass Biotechnology Co., Ltd. Recent Developments
  37. 8.7 Biomarker Technologies
  38. 8.7.1 Biomarker Technologies Company Information
  39. 8.7.2 Biomarker Technologies Business Overview
  40. 8.7.3 Biomarker Technologies lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biomarker Technologies lncRNA Sequencing Service Product Portfolio
  42. 8.7.5 Biomarker Technologies Recent Developments
  43. 8.8 Azenta
  44. 8.8.1 Azenta Company Information
  45. 8.8.2 Azenta Business Overview
  46. 8.8.3 Azenta lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Azenta lncRNA Sequencing Service Product Portfolio
  48. 8.8.5 Azenta Recent Developments
  49. 8.9 BGI Genomics
  50. 8.9.1 BGI Genomics Company Information
  51. 8.9.2 BGI Genomics Business Overview
  52. 8.9.3 BGI Genomics lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BGI Genomics lncRNA Sequencing Service Product Portfolio
  54. 8.9.5 BGI Genomics Recent Developments
  55. 8.10 Annoroad Gene Technology
  56. 8.10.1 Annoroad Gene Technology Company Information
  57. 8.10.2 Annoroad Gene Technology Business Overview
  58. 8.10.3 Annoroad Gene Technology lncRNA Sequencing Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Annoroad Gene Technology lncRNA Sequencing Service Product Portfolio
  60. 8.10.5 Annoroad Gene Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst